Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients
- 79 Downloads
Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson’s Disease (PD) and in a group of female patients with Alzheimer’s Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients.
As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.
KeywordsHomocysteine Alzheimer’s disease Parkinson’s disease Dehydroepiandrosterone sulphate Human patients
Unable to display preview. Download preview PDF.
- Agnati LF, S Genedani, G Rasio, M Galantucci, S Saltini, M Filaferro, R Franco, F Mora, S Ferrè and K Fuxe (2004, 12 May online) Studies on homocysteine plasma levels in Alzheimer’s patients, relevance for neurodegeneration.J. Neural Transm. Google Scholar
- Agnati LF, D Guidolin, S Genedani, S Ferré, A Bigiani, A Woods and K Fuxe (submitted) How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics.J. Mol. Neurosci. Google Scholar
- Asaba H, K Hosoya, H Takanaga, S Ohtsuki, E Tamura, T Takizawa and T Terasaki (2000) Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.J. Neurochem. 75, 1907–1916.PubMedCrossRefGoogle Scholar
- Baulieu EE, P Robel and M Schumacher (1999)Neurosteroids, A New Regulatory Function in the Nervous System (Humana Press: Totawa, NJ, USA).Google Scholar
- Daniel WW (1999)Biostatistics: A Foundation for Analysis in the Health Sciences (John Wiley: New York NY, USA).Google Scholar
- Fowler B (2001) Transport and tissue distribution of homocysteine and relatedS-adenosyl compounds, InHomocysteine in Health and Disease (Carmel R and DW Jacobsen, Eds.) Cambridge Univeristy Press: Cambridge), pp 163–175.Google Scholar
- Fuxe K, K Andersson, R Schwarcz, LF Agnati, M Pérez de la Mora, T Hökfelt, M Goldstein, L Ferland, L Possani and R Tapia (1979) Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate and opioid peptides.Adv. Neurol. 24, 199–215.Google Scholar
- Magni E, G Binetti, A Bianchetti, R Rozzini and M Trabucchi (1996) Mini-mental state examination: a normative study in italian elderly population.Eur. J. Neurol. 3, 1–5.Google Scholar
- Mazat L, S Lafon, B Debuire, JF Tessier, JF Dartigues and EE Baulieu (2001) Prospective measurements of dehydroepiandros-terone sulfate in a cohort of elderly subjects: relationship, to gender, subjective health, smoking habits, and 10-year mortality.Proc. Natl. Acad. Sci. USA 98, 8145–8150.PubMedCrossRefGoogle Scholar
- Schumacher M, S Weill-Engerer, P Liere, F Robert, RJM Franklin, LM Garcia-Segura, JJ Lambert, W Mayo, RC Melcangi, A Parducz, U Suter, C Carelli, EE Baulieu and Y Akwa (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system.Prog. Neurobiol. 71, 3–29.PubMedCrossRefGoogle Scholar
- Weill-Engerer S, JP David, V Sazdovitch, P Liere, B Eychenne, A Pianos, M Shumacher, A Delacourte, EE Baulieu and Y Akwa (2002) Neurosteroids quantification in human brain regions: comparison between Alzheimer’s and nondemented patients.J. Clin. Endocrinol. Metab.. 87, 5138–5143.PubMedCrossRefGoogle Scholar